| Year |
Citation |
Score |
| 2020 |
Chen J, Madireddi S, Nagarkar D, Migdal M, Vander Heiden J, Chang D, Mukhyala K, Selvaraj S, Kadel EE, Brauer MJ, Mariathasan S, Hunkapiller J, Jhunjhunwala S, Albert ML, Hammer C. In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales. Briefings in Bioinformatics. PMID 32940337 DOI: 10.1093/Bib/Bbaa223 |
0.322 |
|
| 2019 |
Kong Y, Rose CM, Cass AA, Williams AG, Darwish M, Lianoglou S, Haverty PM, Tong AJ, Blanchette C, Albert ML, Mellman I, Bourgon R, Greally J, Jhunjhunwala S, Chen-Harris H. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nature Communications. 10: 5228. PMID 31745090 DOI: 10.1038/S41467-019-13035-2 |
0.36 |
|
| 2019 |
Fehlings M, Jhunjhunwala S, Kowanetz M, O'Gorman WE, Hegde PS, Sumatoh H, Lee BH, Nardin A, Becht E, Flynn S, Ballinger M, Newell EW, Yadav M. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. Journal For Immunotherapy of Cancer. 7: 249. PMID 31511069 DOI: 10.1186/S40425-019-0695-9 |
0.339 |
|
| 2019 |
de Almeida Nagata DE, Chiang EY, Jhunjhunwala S, Caplazi P, Arumugam V, Modrusan Z, Chan E, Merchant M, Jin L, Arnott D, Romero FA, Magnuson S, Gascoigne KE, Grogan JL. Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Cell Reports. 27: 269-281.e4. PMID 30943407 DOI: 10.1016/J.Celrep.2019.03.008 |
0.309 |
|
| 2019 |
Yadav M, Fehlings M, Jhunjhunwala S, O'Gorman B, Hegde P, Kim L, Nardin A, Flynn S, Sumatoh H, Ballinger M, Shames D, Lee BH, Newell E. Abstract 4055: Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung cancer patients responding to atezolizumab treatment Cancer Research. 79: 4055-4055. DOI: 10.1158/1538-7445.Am2019-4055 |
0.368 |
|
| 2018 |
Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel Iii EE, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. PMID 29443960 DOI: 10.1038/Nature25501 |
0.332 |
|
| 2018 |
Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Yang Y, Şenbabaoğlu Y, Mellman I, Chen DS, et al. Abstract 2979: A balance of genomic instability, tumor-immune contexture and TGF-β signaling contributing to exclusion of T cells governs response to PD-L1 checkpoint blockade Cancer Research. 78: 2979-2979. DOI: 10.1158/1538-7445.Am2018-2979 |
0.342 |
|
| 2017 |
Viotti M, Wilson C, McCleland M, Koeppen H, Haley B, Jhunjhunwala S, Klijn C, Modrusan Z, Arnott D, Classon M, Stephan JP, Mellman I. SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer. The Journal of Cell Biology. PMID 29229751 DOI: 10.1083/Jcb.201705031 |
0.333 |
|
| 2017 |
Guler GD, Tindell CA, Pitti R, Wilson C, Nichols K, KaiWai Cheung T, Kim HJ, Wongchenko M, Yan Y, Haley B, Cuellar T, Webster J, Alag N, Hegde G, Jackson E, ... ... Jhunjhunwala S, et al. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. Cancer Cell. PMID 28781121 DOI: 10.1016/J.Ccell.2017.07.002 |
0.335 |
|
| 2017 |
Capietto AH, Jhunjhunwala S, Delamarre L. Characterizing neoantigens for personalized cancer immunotherapy. Current Opinion in Immunology. 46: 58-65. PMID 28478383 DOI: 10.1016/J.Coi.2017.04.007 |
0.305 |
|
| 2016 |
Rother MB, Palstra RJ, Jhunjhunwala S, van Kester KA, van IJcken WF, Hendriks RW, van Dongen JJ, Murre C, van Zelm MC. Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci. Nucleic Acids Research. 44: 175-86. PMID 26384565 DOI: 10.1093/Nar/Gkv928 |
0.571 |
|
| 2016 |
Wallin J, Pishvaian MJ, Hernandez G, Yadav M, Jhunjhunwala S, Delamarre L, He X, Powderly J, Lieu C, Eckhardt SG, Hurwitz H, Hochster HS, Murphy J, Leveque V, Cha E, et al. Abstract 2651: Clinical activity and immune correlates from a phase Ib study evaluating atezolizumab (anti-PDL1) in combination with FOLFOX and bevacizumab (anti-VEGF) in metastatic colorectal carcinoma Cancer Research. 76: 2651-2651. DOI: 10.1158/1538-7445.Am2016-2651 |
0.361 |
|
| 2014 |
Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, Franci C, Cheung TK, Fritsche J, Weinschenk T, Modrusan Z, Mellman I, Lill JR, Delamarre L. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 515: 572-6. PMID 25428506 DOI: 10.1038/Nature14001 |
0.33 |
|
| 2014 |
Mayba O, Gilbert HN, Liu J, Haverty PM, Jhunjhunwala S, Jiang Z, Watanabe C, Zhang Z. MBASED: allele-specific expression detection in cancer tissues and cell lines. Genome Biology. 15: 405. PMID 25315065 DOI: 10.1186/S13059-014-0405-3 |
0.315 |
|
| 2014 |
Liu J, McCleland M, Stawiski EW, Gnad F, Mayba O, Haverty PM, Durinck S, Chen YJ, Klijn C, Jhunjhunwala S, Lawrence M, Liu H, Wan Y, Chopra V, Yaylaoglu MB, et al. Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer. Nature Communications. 5: 3830. PMID 24807215 DOI: 10.1038/Ncomms4830 |
0.313 |
|
| 2012 |
Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, Gnad F, Guan Y, Gilbert HN, Stinson J, Klijn C, Guillory J, Bhatt D, Vartanian S, Walter K, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Research. 22: 2315-27. PMID 23033341 DOI: 10.1101/Gr.140988.112 |
0.321 |
|
| 2011 |
Mercer EM, Lin YC, Benner C, Jhunjhunwala S, Dutkowski J, Flores M, Sigvardsson M, Ideker T, Glass CK, Murre C. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity. 35: 413-25. PMID 21903424 DOI: 10.1016/J.Immuni.2011.06.013 |
0.575 |
|
| 2010 |
Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, Ideker T, Glass CK, Murre C. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nature Immunology. 11: 635-43. PMID 20543837 DOI: 10.1038/Ni.1891 |
0.57 |
|
| 2009 |
Jhunjhunwala S, van Zelm MC, Peak MM, Murre C. Chromatin architecture and the generation of antigen receptor diversity. Cell. 138: 435-48. PMID 19665968 DOI: 10.1016/J.Cell.2009.07.016 |
0.524 |
|
| 2008 |
Jhunjhunwala S, van Zelm MC, Peak MM, Cutchin S, Riblet R, van Dongen JJ, Grosveld FG, Knoch TA, Murre C. The 3D structure of the immunoglobulin heavy-chain locus: implications for long-range genomic interactions. Cell. 133: 265-79. PMID 18423198 DOI: 10.1016/J.Cell.2008.03.024 |
0.518 |
|
| 2005 |
Sayegh CE, Sayegh C, Jhunjhunwala S, Riblet R, Murre C. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes & Development. 19: 322-7. PMID 15687256 DOI: 10.1101/Gad.1254305 |
0.564 |
|
| Show low-probability matches. |